TY - JOUR
T1 - Electrophysiological effects of risperidone in mammalian cardiac cells
AU - Magyar, János
AU - Bányász, Tamás
AU - Bagi, Zsolt
AU - Pacher, Pál
AU - Szentandrássy, Norbert
AU - Fülöp, László
AU - Kecskeméti, Valéria
AU - Nánási, Péter P.
N1 - Funding Information:
Acknowledgements This study was supported by grants to PPN (OTKA-T037334, FKFP-0243/2000 and ETT-244/2000), to JM (ETT-52/2000) and to VK (ETT-155/2000) obtained from the Hungarian Research Found, Hungarian Ministry of Education and Hungarian Ministry of Health. Further support was obtained from National Research & Development Programmes (NKFP-1A/0011/ 2002). The experiments comply with the current laws of Hungary.
PY - 2002
Y1 - 2002
N2 - In this study, the effects of risperidone, the widely used antipsychotic drug, on isolated canine ventricular myocytes and guinea-pig papillary muscles were analyzed using conventional microelectrode and whole cell voltage-clamp techniques. Risperidone concentration-dependently lengthened action potential duration in guinea-pig papillary muscles (EC50=0.29±0.02 μM) and single canine ventricular myocytes (EC50=0.48±0.14 μM). This effect was reversible, showed reverse rate dependence, and it was most prominent on the terminal portion of repolarization. No significant effect of risperidone on the resting membrane potential, action potential amplitude or maximum rate of depolarization was observed. In voltage-clamped canine ventricular myocytes risperidone caused concentration-dependent block of the rapid component of the delayed rectifier K+ current (IKr), measured as outward current tails at -40 mV, with an IC50 of 0.92±0.26 μM. Suppression of IKr was not associated with changes in activation or deactivation kinetics. High concentration of risperidone (10 μM) suppressed also the slow component of the delayed rectifier K+ current (IKs) by 9.6±1.5% at +50 mV. These effects of risperidone developed rapidly and were readily reversible. Risperidone had no significant effect on the amplitude of other K+ currents (IK1 and Ito). The inhibition of cardiac IKr current by risperidone may explain the cardiac side-effects observed occasionally with the drug. Our results suggest that risperidone displays class III antiarrhythmic properties, and as such, may produce QTc prolongation, especially in patients with long QT syndrome. Therefore, in psychotic patients having also cardiac disorders, ECG control may be suggested during risperidone therapy.
AB - In this study, the effects of risperidone, the widely used antipsychotic drug, on isolated canine ventricular myocytes and guinea-pig papillary muscles were analyzed using conventional microelectrode and whole cell voltage-clamp techniques. Risperidone concentration-dependently lengthened action potential duration in guinea-pig papillary muscles (EC50=0.29±0.02 μM) and single canine ventricular myocytes (EC50=0.48±0.14 μM). This effect was reversible, showed reverse rate dependence, and it was most prominent on the terminal portion of repolarization. No significant effect of risperidone on the resting membrane potential, action potential amplitude or maximum rate of depolarization was observed. In voltage-clamped canine ventricular myocytes risperidone caused concentration-dependent block of the rapid component of the delayed rectifier K+ current (IKr), measured as outward current tails at -40 mV, with an IC50 of 0.92±0.26 μM. Suppression of IKr was not associated with changes in activation or deactivation kinetics. High concentration of risperidone (10 μM) suppressed also the slow component of the delayed rectifier K+ current (IKs) by 9.6±1.5% at +50 mV. These effects of risperidone developed rapidly and were readily reversible. Risperidone had no significant effect on the amplitude of other K+ currents (IK1 and Ito). The inhibition of cardiac IKr current by risperidone may explain the cardiac side-effects observed occasionally with the drug. Our results suggest that risperidone displays class III antiarrhythmic properties, and as such, may produce QTc prolongation, especially in patients with long QT syndrome. Therefore, in psychotic patients having also cardiac disorders, ECG control may be suggested during risperidone therapy.
KW - Action potential duration
KW - Antidepressant drugs
KW - Cardiac myocytes
KW - Potassium currents
KW - Risperidone
UR - http://www.scopus.com/inward/record.url?scp=0036381563&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036381563&partnerID=8YFLogxK
U2 - 10.1007/s00210-002-0595-1
DO - 10.1007/s00210-002-0595-1
M3 - Article
C2 - 12237749
AN - SCOPUS:0036381563
SN - 0028-1298
VL - 366
SP - 350
EP - 356
JO - Naunyn-Schmiedeberg's Archives of Pharmacology
JF - Naunyn-Schmiedeberg's Archives of Pharmacology
IS - 4
ER -